Table 2:
Cox regression for individual predictors of death following MWA.
| Parameter | HR (95% CI) | P-value |
|---|---|---|
| Age (y) | ||
| 55–65 | Ref value 1 | 0.114 |
| 66–75 | 6.8 (0.7, 70.4) | 0.108 |
| >75 | 1.6 (0.2, 16.2) | 0.707 |
| Female gender | 0.1 (0.03, 0.7) | 0.014 |
| Smoking history (PY) | 1.0 (0.95, 1.01) | 0.121 |
| Time to ablation | 1.0 (0.99, 1.01) | 0.950 |
| Tumor longest dim. | 1.1 (1.0, 1.3) | 0.197 |
| Pred. FVC % | 1.0 (0.95, 1.04) | 0.843 |
| Pred. FEV1 % | 1.0 (0.91, 1.03) | 0.295 |
| FEV1:FVC ratio | 0.94 (0.85, 1.03) | 0.178 |
| Diabetes | 1.0 (0.16, 6.5) | 0.997 |
| CAD | 0.7 (0.11, 0.4.2) | 0.663 |
| CHF | 1.8 (0.2, 19.1) | 0.623 |
| HLD | 4.0 (0.8, 20.1) | 0.091 |
| A. Fib | 1.1 (0.18, 6.6) | 0.937 |
| Obesity | 1.1 (0.17, 6.6) | 0.945 |
| OSA | 2.2 (0.5, 10.5) | 0.327 |
| HTN | 1.5 (0.25, 9.1) | 0.648 |
| CKD | 2.5 (0.18, 34.8) | 0.503 |
y: Year, PY: Pack-year, dim.: Dimension, pred. FVC%: Predicted forced vital capacity, FEV1%: Forced expiration volume in 1 s, CHF: Congestive heart failure, HTN: Hypertension, CKD: Chronic kidney disease, HLD: Hyperlipidemia, A. Fib: Atrial fibrillation, CAD: Coronary artery disease, OSA: Obstructive sleep apnea